Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.
This isn’t the first time the AI company has been accused of...
If anyone was holding out hope that the Oversight Board would provide...
Snap has acquired Saturn, a calendar app that helps students manage their...
The Pope is sending a message to tech executives about necessary AI...
Leave a comment